Physician profile
Stephen V Gordon
NPI 1912908518
$1,663.13
in general payments reported to CMS, 2019-2025
12 companies · $651 in 2025
The $651 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.77 · 2020: $18.31 · 2021: $25.31 · 2022: $169 · 2023: $574 · 2024: $184 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.51 |
| Education | $182.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $637.02 | 2023-2025 | Da Vinci Surgical System |
| Aroa Biosurgery Incorporated | $434.46 | 2022-2025 | |
| Tela Bio, INC. | $217.56 | 2022-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Abbvie INC. | $107.41 | 2021-2025 | |
| Kerecis Limited | $63.53 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $48.72 | 2023 | Ligasure |
| Covidien LP | $41.77 | 2019 | |
| Polynovo North America LLC | $27.12 | 2023 | |
| Davol INC. | $25.55 | 2025 | Phasix Mesh |
| Becton, Dickinson and Company | $24.27 | 2024 | Phasix Mesh |
| Allergan, INC. | $18.31 | 2020 | |
| Stryker Corporation | $17.41 | 2023 | 1688, Spy-Phi System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.